Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience
帕博利珠单抗联合新辅助化疗治疗早期三阴性乳腺癌,化疗剂量减少或停药的有害影响:一项多中心研究
期刊:Clinical Breast Cancer
影响因子:2.5
doi:10.1016/j.clbc.2024.08.005
Krishnan, Jayasree; Patel, Archit; Roy, Arya Mariam; Alharbi, Malak; Kapoor, Ankita; Yao, Song; Khoury, Thaer; Hong, Chi-Chen; Held, Nicole; Chakraborty, Anumita; Kaliniski, Pawel; Salman, Ahmed; Catalfamo, Kayla; Attwood, Kristopher; Kirtani, Vatsala; Shaikh, Saba S; Chaudhary, Lubna N; Gandhi, Shipra